Trials / Completed
CompletedNCT04236830
Silver Diamine Fluoride/ Potassium Iodide in Indirect Pulp Capping of Young Permanent Molars
Effectiveness of Silver Diamine Fluoride/ Potassium Iodide in Indirect Pulp Capping of Young Permanent Molars (a Randomized Controlled Clinical Trial)
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 108 (actual)
- Sponsor
- Nourhan M.Aly · Academic / Other
- Sex
- All
- Age
- 6 Years – 9 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate and compare the clinical effectiveness of 38% silver diamine fluoride with and without potassium iodide with that of resin modified glass ionomer cement in indirect pulp capping of young permanent molars.
Detailed description
A sample of children with an age range of 6-9 years, having a first permanent molar erupted with deep occlusal carious lesion, will be selected from the outpatient clinic of Pediatric Dentistry and Public Health Department, Faculty of Dentistry, Alexandria University after securing necessary consents. All selected 108 first permanent molars will be randomly equally allocated into three groups according to capping material used. Group I (n=36) SDF/ KI and Group II (n=36) SDF and Group III (n=36) Glass ionomer cement. Indirect pulp capping treatment procedure will be performed with identical protocols except for the capping material to be used and its application will be according to manufacturer's instructions. Glass ionomer cement will be used as a base and resin-based composite restoration will be used in the three groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Silver diamine fluoride/ potassium iodide | Thirty six first permanent molars will receive 38% SDF/KI as an indirect pulp capping material. |
| DRUG | Silver diamine fluoride | Thirty six first permanent molars will receive 38% SDF as an indirect pulp capping material. |
| DRUG | Resin modified glass ionomer cement | Thirty six first permanent molars will receive RMGIC as an indirect pulp capping material. |
Timeline
- Start date
- 2019-11-01
- Primary completion
- 2021-03-01
- Completion
- 2021-03-25
- First posted
- 2020-01-22
- Last updated
- 2022-05-19
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04236830. Inclusion in this directory is not an endorsement.